Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-03-22
2005-03-22
Weber, Jon (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
Reexamination Certificate
active
06869778
ABSTRACT:
Variants of tissue plasminogen factor exhibit significantly enhanced fibrin stimulation, dramatically increased discrimination among fibrin co-factors, marked resistance to inhibition by PAI-1, and substantially increased zymogenicity, a combination of properties that enhance the therapeutic utility of the enzyme.
REFERENCES:
patent: 5246850 (1993-09-01), Bennett et al.
patent: 5520913 (1996-05-01), Anderson et al.
patent: 5525477 (1996-06-01), Hassouna
patent: 5616486 (1997-04-01), Anderson et al.
patent: 0 199 574 (1986-10-01), None
patent: 0 201 153 (1986-11-01), None
patent: 0 225 286 (1987-06-01), None
patent: 0 231 624 (1987-08-01), None
patent: 0 233 013 (1987-08-01), None
patent: 0 238 304 (1987-09-01), None
patent: 0 240 334 (1987-10-01), None
patent: 0 241 209 (1987-10-01), None
patent: 0 290 118 (1988-11-01), None
patent: 0 292 009 (1988-11-01), None
patent: 0 293 934 (1988-12-01), None
patent: 0 293 936 (1988-12-01), None
patent: 0 297 066 (1988-12-01), None
patent: 0 299 706 (1989-01-01), None
patent: 0 351 246 (1990-01-01), None
patent: WO 8704722 (1987-08-01), None
patent: WO 8805081 (1988-07-01), None
patent: WO 8810119 (1988-12-01), None
patent: WO 8900191 (1989-01-01), None
patent: WO 9002798 (1990-03-01), None
Petersen, et al., Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416, 1990,Biochemistry, 29(14):3451-3457.
Tachias, et al., Variants of tissue-type plasminogen activator which display substantially enhanced stimulation by fibrin, 1995,J. Biol. Chem., 270(31):18319-18322.
Krause, et al., Properties of molecular variants of tissue-type plasminogen activator, 1989,Arzneim.-Forsch., 39:632-637.
van Zonneveld, et al., Mapping of epitopes on human tissue-type plasminogen activator with recombinant deletion mutant proteins, 1987,Thrombosis&Haemostasis, 57(1):82-86.
Browne, et al., A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain, 1988,J. Biol. Chem., 263:1599-1602.
Madison, et al., Serpin resistant mutants of human tissue-type plasminogen activator, 1989,Nature, 339:721-724.
Higgins, et al., The effect of the one-chain to two-chain conversion in tissue plasminogen activator: Characterization of mutations at position 275, 1990,Thrombosis Res., 57:527-539.
Lamba, et al., “The 2.3 A Crystal Structure of the Catalytic Domain of Recombinant Two-chain Human Tissue-type Plasminogen Activator”,J. Mol. Biol. 258: 117-135 (1996).
Strandberg, et al., “Variants of Tissue-type Plasminogen Activator with Substantially Enhanced Response and Selectivity toward Fibrin Co-factors”,J. Biol. Chem. 270(40): 23444-23449 (1995).
Tate, et al., “Functional Role of Proteolytic Cleavage at Arginine-275 of Human Tissue Plasminogen Activator as Assessed by Site-Directed Mutagensis”,Biochemistry 26; 338-343 (1987).
Fitting Thomas
McCarthy Michael J.
Snedden Sheridan
The Scripps Research Institute
Weber Jon
LandOfFree
Tissue type plasminogen activator (t-PA) variants:... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tissue type plasminogen activator (t-PA) variants:..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue type plasminogen activator (t-PA) variants:... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3407962